SCHEMBL22686789

SCHEMBL22686789

COc1ncc(-c2ccc(C3(NC(=O)c4ccc(Cl)cc4)CC3)cc2)c(N)n1

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ WDR91 A4D1P6 3/20 0.43
▸ HSD11B1 P28845 1/20 0.41
▸ MAP4K4 O95819 5/20 0.40
▸ ROCK2 O75116 3/20 0.40
▸ ROCK1 Q13464 3/20 0.40
▸ HDAC3 O15379 1/20 0.40
▸ HDAC1 Q13547 1/20 0.40
▸ HDAC2 Q92769 1/20 0.40
▸ HDAC6 Q9UBN7 1/20 0.40
▸ DYRK1A Q13627 1/20 0.39
▸ DYRK1B Q9Y463 1/20 0.39
▸ BTK Q06187 1/20 0.38
▸ OPRD1 P41143 1/20 0.38
▸ KCNH2 Q12809 1/20 0.38
▸ CXCR3 P49682 2/20 0.38
▸ AKT1 P31749 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22685311 0.92 WDR91 (0.55) WDR91HSD11B1MAP4K4DYRK1ADYRK1B
SCHEMBL22686788 0.86 HDAC3 (0.46) WDR91MAP4K4HDAC3HDAC1HDAC2
SCHEMBL22686783 0.84 WDR91 (0.42) WDR91MAP4K4ROCK2ROCK1HDAC3
SCHEMBL22685237 0.83 BTK (0.41) WDR91HSD11B1MAP4K4HDAC3HDAC1
SCHEMBL22685249 0.82 WDR91 (0.41) WDR91MAP4K4ROCK2ROCK1HDAC3
SCHEMBL22686791 0.81 WDR91 (0.44) WDR91HSD11B1MAP4K4HDAC3HDAC1
SCHEMBL22685198 0.79 WDR91 (0.53) WDR91MAP4K4HDAC3HDAC1HDAC2
SCHEMBL22685255 0.79 HDAC3 (0.39) MAP4K4HDAC3HDAC1HDAC2HDAC6
SCHEMBL22685238 0.77 HDAC3 (0.47) WDR91HSD11B1HDAC3HDAC1HDAC2
SCHEMBL22685183 0.77 MALT1 (0.44) WDR91ROCK2ROCK1HDAC3HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020228823-A1 NOVEL AMIDE COMPOUNDS AND USES THEREOF HUTCHISON MEDIPHARMA LIMITED (CN) 2020-11-19 — — WO disclosed
Send feedback